Evidence map›Paper›PMID 36945475›Full record

ArticleResearch square2023

Effect of Reduced Versus Usual Lipid Emulsion Dosing on Bilirubin Neurotoxicity and Neurodevelopmental Impairment in Extremely Preterm Infants: Study Protocol for a Randomized Controlled Trial.

Lindsay Holzapfel, Cody Arnold, Jon Tyson, Steven Shapiro, Eric Reynolds, Claudia Pedroza, Emily Stephens, Alan Kleinfeld, Andrew Huber, Matthew Rysavy and 2 more

Open access · greenFull text readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Lindsay HolzapfelThe University of Texas Health Science Center at Houston.
Cody ArnoldStanford University.
Jon TysonThe University of Texas Health Science Center at Houston.
Steven ShapiroUniversity of Kansas Medical Center.
Eric ReynoldsThe University of Texas Health Science Center at Houston.
Claudia PedrozaThe University of Texas Health Science Center at Houston.
Emily StephensThe University of Texas Health Science Center at Houston.
Alan KleinfeldFluoresprobe Sciences (United States).
Andrew HuberFluoresprobe Sciences (United States).
Matthew RysavyThe University of Texas Health Science Center at Houston.
Amir KhanThe University of Texas Health Science Center at Houston.
Maria Del Mar Romero LopezThe University of Texas Health Science Center at Houston.
The University of Texas Health Science Center at Houston · USFluoresprobe Sciences (United States) · USStanford University · USUniversity of Kansas Medical Center · US

Funding

Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
NCATS NIH HHS KL2 TR003168
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36945475
PMCPMC10029123
OpenAlexW4323350406

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.